Cargando…

Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation

OBJECTIVES: To assess clinical service value of STI point-of-care test (POCT) use in a ‘sample first’ clinical pathway (patients providing samples on arrival at clinic, before clinician consultation). Specific outcomes were: patient acceptability; whether a rapid nucleic acid amplification test (NAA...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding-Esch, Emma M, Nori, Achyuta V, Hegazi, Aseel, Pond, Marcus J, Okolo, Olanike, Nardone, Anthony, Lowndes, Catherine M, Hay, Phillip, Sadiq, S Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574381/
https://www.ncbi.nlm.nih.gov/pubmed/28159916
http://dx.doi.org/10.1136/sextrans-2016-052988
_version_ 1783259824649142272
author Harding-Esch, Emma M
Nori, Achyuta V
Hegazi, Aseel
Pond, Marcus J
Okolo, Olanike
Nardone, Anthony
Lowndes, Catherine M
Hay, Phillip
Sadiq, S Tariq
author_facet Harding-Esch, Emma M
Nori, Achyuta V
Hegazi, Aseel
Pond, Marcus J
Okolo, Olanike
Nardone, Anthony
Lowndes, Catherine M
Hay, Phillip
Sadiq, S Tariq
author_sort Harding-Esch, Emma M
collection PubMed
description OBJECTIVES: To assess clinical service value of STI point-of-care test (POCT) use in a ‘sample first’ clinical pathway (patients providing samples on arrival at clinic, before clinician consultation). Specific outcomes were: patient acceptability; whether a rapid nucleic acid amplification test (NAAT) for Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) could be used as a POCT in practice; feasibility of non-NAAT POCT implementation for Trichomonas vaginalis (TV) and bacterial vaginosis (BV); impact on patient diagnosis and treatment. METHODS: Service evaluation in a south London sexual health clinic. Symptomatic female and male patients and sexual contacts of CT/NG-positive individuals provided samples for diagnostic testing on clinic arrival, prior to clinical consultation. Tests included routine culture and microscopy; CT/NG (GeneXpert) NAAT; non-NAAT POCTs for TV and BV. RESULTS: All 70 (35 males, 35 females) patients approached participated. The ‘sample first’ pathway was acceptable, with >90% reporting they were happy to give samples on arrival and receive results in the same visit. Non-NAAT POCT results were available for all patients prior to leaving clinic; rapid CT/NG results were available for only 21.4% (15/70; 5 males, 10 females) of patients prior to leaving clinic. Known negative CT/NG results led to two females avoiding presumptive treatment, and one male receiving treatment directed at possible Mycoplasma genitalium infection causing non-gonococcal urethritis. Non-NAAT POCTs detected more positives than routine microscopy (TV 3 vs 2; BV 24 vs 7), resulting in more patients receiving treatment. CONCLUSIONS: A ‘sample first’ clinical pathway to enable multiple POCT use was acceptable to patients and feasible in a busy sexual health clinic, but rapid CT/NG processing time was too long to enable POCT use. There is need for further development to improve test processing times to enable POC use of rapid NAATs.
format Online
Article
Text
id pubmed-5574381
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55743812017-09-06 Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation Harding-Esch, Emma M Nori, Achyuta V Hegazi, Aseel Pond, Marcus J Okolo, Olanike Nardone, Anthony Lowndes, Catherine M Hay, Phillip Sadiq, S Tariq Sex Transm Infect Clinical OBJECTIVES: To assess clinical service value of STI point-of-care test (POCT) use in a ‘sample first’ clinical pathway (patients providing samples on arrival at clinic, before clinician consultation). Specific outcomes were: patient acceptability; whether a rapid nucleic acid amplification test (NAAT) for Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) could be used as a POCT in practice; feasibility of non-NAAT POCT implementation for Trichomonas vaginalis (TV) and bacterial vaginosis (BV); impact on patient diagnosis and treatment. METHODS: Service evaluation in a south London sexual health clinic. Symptomatic female and male patients and sexual contacts of CT/NG-positive individuals provided samples for diagnostic testing on clinic arrival, prior to clinical consultation. Tests included routine culture and microscopy; CT/NG (GeneXpert) NAAT; non-NAAT POCTs for TV and BV. RESULTS: All 70 (35 males, 35 females) patients approached participated. The ‘sample first’ pathway was acceptable, with >90% reporting they were happy to give samples on arrival and receive results in the same visit. Non-NAAT POCT results were available for all patients prior to leaving clinic; rapid CT/NG results were available for only 21.4% (15/70; 5 males, 10 females) of patients prior to leaving clinic. Known negative CT/NG results led to two females avoiding presumptive treatment, and one male receiving treatment directed at possible Mycoplasma genitalium infection causing non-gonococcal urethritis. Non-NAAT POCTs detected more positives than routine microscopy (TV 3 vs 2; BV 24 vs 7), resulting in more patients receiving treatment. CONCLUSIONS: A ‘sample first’ clinical pathway to enable multiple POCT use was acceptable to patients and feasible in a busy sexual health clinic, but rapid CT/NG processing time was too long to enable POCT use. There is need for further development to improve test processing times to enable POC use of rapid NAATs. BMJ Publishing Group 2017-09 2017-02-03 /pmc/articles/PMC5574381/ /pubmed/28159916 http://dx.doi.org/10.1136/sextrans-2016-052988 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Clinical
Harding-Esch, Emma M
Nori, Achyuta V
Hegazi, Aseel
Pond, Marcus J
Okolo, Olanike
Nardone, Anthony
Lowndes, Catherine M
Hay, Phillip
Sadiq, S Tariq
Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation
title Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation
title_full Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation
title_fullStr Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation
title_full_unstemmed Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation
title_short Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation
title_sort impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. a service evaluation
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574381/
https://www.ncbi.nlm.nih.gov/pubmed/28159916
http://dx.doi.org/10.1136/sextrans-2016-052988
work_keys_str_mv AT hardingeschemmam impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT noriachyutav impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT hegaziaseel impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT pondmarcusj impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT okoloolanike impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT nardoneanthony impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT lowndescatherinem impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT hayphillip impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation
AT sadiqstariq impactofdeployingmultiplepointofcaretestswithasamplefirstapproachonasexualhealthclinicalcarepathwayaserviceevaluation